Tirzepatide and major adverse limb events: Insights from a multicenter real-world analysis in PAD and diabetes patients
{{output}}
Aims: Peripheral artery disease (PAD) is a major diabetic complication and a leading cause of amputation. While GLP-1 receptor agonists (GLP-1 RAs) provide cardiovascular and limb protection, the impact of tirzepatide, a dual GLP... ...
